Exelixis Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? Exelixis Inc. Common Stock trades at $58.72 (market cap $14.62B), while Ovintiv Inc. (DE) trades at $62.88 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is the larger of the two by market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Ovintiv Inc. (DE) for 0 Days on average.
| EXEL | OVV | |
|---|---|---|
Market Cap | $14.62B | $17.53B |
Volume | 2,684,957 | 3,002,714 |
Sector | Health | Energy |
52-Week High | $59.13 | $66.97 |
52-Week Low | $34.54 | $35.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $21.86B |
Dividend Yield | — | 1.89% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →